previous compound ID: 1813 next compound
InChIKey: QFJCIRLUMZQUOT-HPLJOQBZSA-N
SMILES: C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "J Goepp" "D Rotin" "SD Macknight" "R Robert" "GW Carlile" "JW Hanrahan" "E Matthes" "B Kus" "DY Thomas"

chemical graph of compound 1813





CID is 5284616
synonyms found at PubChem are:
Rapamycin, Sirolimus, 53123-88-9, Rapamune, (-)-Rapamycin, AY-22989, Rapammune, sirolimusum, Supralimus, RAPA, Rapamycin (Sirolimus), Antibiotic AY 22989, AY 22989, UNII-W36ZG6FT64, CCRIS 9024, CHEBI:9168, W36ZG6FT64, HSDB 7284, C51H79NO13, NSC 226080, DE-109, WY-090217, NCGC00021305-05, DSSTox_CID_3582, DSSTox_RID_77091, DSSTox_GSID_23582, Perceiva, Cypher, SILA 9268A, LCP-Siro, Wy 090217, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, Sirolimus (RAPAMUNE), CAS-53123-88-9, Rapamycin C-7, analog 4, Sirolimus [USAN:BAN:INN], MS-R001, rapalimus, NSC226080, 1fkb, 1pbk, NCGC00181146-01, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone, RAP, S1039, PubChem16645, BiomolKI2_000084, SCHEMBL3463, Rapamycin,Sirolimus,Rapamune, BIDD:PXR0165, 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine, Sirolimus [USAN:INN:BAN], DTXSID5023582, BDBM36609, SYN1185, MolPort-003-959-433, HMS2089A21, HMS3403F11, EX-A1044, Tox21_110870, Tox21_112750, AC-722, BDBM50064359, MFCD00867594, AKOS015850976, AKOS015961618, AY22989, CCG-100684, CS-0063, DB00877, RL03960, NCGC00021305-06, NCGC00021305-07, AS-11687, BC207597, HY-10219, LS-143290, UNM-0000358684, A-275, FT-0082351, R0097, Rapamycin, VETRANAL(TM), analytical standard, EC 610-965-5, S-7759, 123R889, Q-201659, BRD-K84937637-001-04-0, BRD-K84937637-001-06-5, BRD-K89626439-001-01-0, Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder, Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%, Sirolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro, 1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin), 1179372-35-0, 1189166-54-8, 1233221-34-5, 1353039-01-6